Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

BK-NM-AMT

From Wikipedia, the free encyclopedia
Monoamine releaser and entactogen
Pharmaceutical compound
BK-NM-AMT
Clinical data
Other namesβk-NM-αMT; β-Keto-N-methyl-αMT; β-Keto-N-methyl-AMT; α,N-dimethyl-β-ketotryptamine; 3-Indoylmethcathinone; β-Oxo-α-methyl-NMT
Drug classSerotonin–dopamine releasing agent;Entactogen
Identifiers
  • 1-(1H-indol-3-yl)-2-(methylamino)propan-1-one
CAS Number
PubChemCID
ChemSpider
Chemical and physical data
FormulaC12H14N2O
Molar mass202.257 g·mol−1
3D model (JSmol)
  • CC(C(=O)C1=CNC2=CC=CC=C21)NC
  • InChI=1S/C12H14N2O/c1-8(13-2)12(15)10-7-14-11-6-4-3-5-9(10)11/h3-8,13-14H,1-2H3
  • Key:NBPRBKHRAWWHFV-UHFFFAOYSA-N

BK-NM-AMT, orβk-NM-αMT, also known asβ-keto-N-methyl-αMT orα,N-dimethyl-β-ketotryptamine, as well as3-indoylmethcathinone, is aserotonin–dopamine releasing agent (SDRA) and putativeentactogen of thetryptamine,α-alkyltryptamine, andβ-ketotryptamine families.[1][2][3][4]

Pharmacology

[edit]

Pharmacodynamics

[edit]

BK-NM-AMT acts as aserotonin–dopamine releasing agent (SDRA).[2][5] TheEC50Tooltip half-maximal effective concentration values of BK-NM-AMT formonoamine release are 41.3 nM forserotonin and 92.8 nM fordopamine in rat brainsynaptosomes, whereas it only induced 55% release ofnorepinephrine at a concentration of 10 μM.[2] Along with certain other tryptamines, such asα-ethyltryptamine (αET),5-chloro-αMT and5-fluoro-αET, it is one of the few SDRAs known.[6][2]

Monoamine release of BK-NM-AMT and related compounds (EC50Tooltip half-maximal effective concentration, nM)
Compound5-HTTooltip SerotoninNETooltip NorepinephrineDATooltip DopamineTypeRef
Tryptamine32.6716164SDRA[7][6]
α-Methyltryptamine (αMT)21.7–6879–11278.6–180SNDRA[8][6]
5-Fluoro-αMT1912632SNDRA[9]
5-Chloro-αMT16343454SDRA[6][9]
BK-NM-AMT41.3ND (55% at 10 μM)92.8SDRA[2][3]
BK-5F-NM-AMT190ND620ND[5]
BK-5Cl-NM-AMT200ND865ND[5]
BK-5Br-NM-AMT295ND2100ND[5]
Notes: The smaller the value, the more strongly the substance releases the neurotransmitter. Theassays were done in rat brainsynaptosomes and humanpotencies may be different. See alsoMonoamine releasing agent § Activity profiles for a larger table with more compounds.

Chemistry

[edit]

BK-NM-AMT, also known as β-keto-N-methyl-α-methyltryptamine, is theN-methyl and β-ketoderivative ofα-methyltryptamine (αMT).[2][4] It is acathinone-like tryptamine and can be thought of as the tryptamine orindole analogue of thephenethylaminemethcathinone (β-keto-N-methylamphetamine).[2][4]

Analogues

[edit]

Analogues of BK-NM-AMT includeα-methyltryptamine (AMT) andα,N-dimethyltryptamine (α,N-DMT; NM-AMT), among others.

Derivatives

[edit]

Several 5-halogenatedderivatives of BK-NM-AMT have also been described.[5] These includeBK-5F-NM-AMT,[10][11]BK-5Cl-NM-AMT,[12][13] andBK-5Br-NM-AMT.[14][15] Like BK-NM-AMT, they induce serotonin and dopamine release.[5] In contrast to many other tryptamines however, these novel β-keto-substituted tryptamine derivatives are inactive asagonists ofserotonin receptors including the5-HT1,5-HT2, and5-HT3 receptors.[5] In addition, unlike other α-alkyltryptamines like αMT, these compounds are inactive asmonoamine oxidase inhibitors (MAOIs).[5]

History

[edit]

BK-NM-AMT and its 5-halogenated analogues werepatented byMatthew Baggott andTactogen in late 2024.[3][4][5]

See also

[edit]

References

[edit]
  1. ^Yadav, Barkha J (16 July 2019).Understanding Structure–Activity Relationship of Synthetic Cathinones (Bath Salts) Utilizing Methylphenidate.VCU Scholars Compass (Thesis). p. 40.doi:10.25772/MJQW-8C64. Retrieved24 November 2024.
  2. ^abcdefgBlough BE, Decker AM, Landavazo A, Namjoshi OA, Partilla JS, Baumann MH, Rothman RB (March 2019)."The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes".Psychopharmacology (Berl).236 (3):915–924.doi:10.1007/s00213-018-5063-9.PMC 6475490.PMID 30341459.
  3. ^abcUS 20240335414, Matthew J. Baggott & Sean Dalziel, "Specialized combinations for mental disorders or mental enhancement", published 10 October 2024, assigned toTactogen Inc. 
  4. ^abcd"1-(1H-indol-3-yl)-2-(methylamino)propan-1-one".PubChem. U.S. National Library of Medicine. Retrieved13 November 2024.
  5. ^abcdefghiWO 2022061242, Matthew Baggott, "Advantageous tryptamine compositions for mental disorders or enhancement", published 2023 March 24, assigned toTactogen 
  6. ^abcdBlough BE, Landavazo A, Partilla JS, Decker AM, Page KM, Baumann MH, Rothman RB (October 2014)."Alpha-ethyltryptamines as dual dopamine-serotonin releasers".Bioorg Med Chem Lett.24 (19):4754–4758.doi:10.1016/j.bmcl.2014.07.062.PMC 4211607.PMID 25193229.
  7. ^Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014)."Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes".Psychopharmacology.231 (21):4135–4144.doi:10.1007/s00213-014-3557-7.PMC 4194234.PMID 24800892.
  8. ^Nagai F, Nonaka R, Satoh Hisashi Kamimura K (March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain".European Journal of Pharmacology.559 (2–3):132–137.doi:10.1016/j.ejphar.2006.11.075.PMID 17223101.
  9. ^abBanks ML, Bauer CT, Blough BE, Rothman RB, Partilla JS, Baumann MH, Negus SS (June 2014)."Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys".Experimental and Clinical Psychopharmacology.22 (3):274–284.doi:10.1037/a0036595.PMC 4067459.PMID 24796848.
  10. ^"1-(5-fluoro-1H-indol-3-yl)-2-(methylamino)propan-1-one".PubChem. Retrieved11 November 2024.
  11. ^"β-Oxo-5-fluoro-α-methyl-NMT".Isomer Design. 10 November 2024. Retrieved11 November 2024.
  12. ^"1-(5-chloro-1H-indol-3-yl)-2-(methylamino)propan-1-one".PubChem. Retrieved11 November 2024.
  13. ^"β-Oxo-5-chloro-α-methyl-NMT".Isomer Design. 10 November 2024. Retrieved11 November 2024.
  14. ^"1-(5-bromo-1H-indol-3-yl)-2-(methylamino)propan-1-one".PubChem. Retrieved11 November 2024.
  15. ^"β-Oxo-5-bromo-α-methyl-NMT".Isomer Design. 10 November 2024. Retrieved11 November 2024.

External links

[edit]
Phenethylamines
Non-ring-extended
Benzodioxoles
(methylenedioxy- or MDxx)
Benzodioxines
(ethylenedioxy-)
Benzofurans
Dihydrobenzofurans
Benzothiophenes
Benzothiazoles
Benzoxathioles
Indanes
Indoles
Naphthalenes
Tetralins
Others
Cyclized
phenethylamines
2-Aminoindanes
1-Aminomethylindanes
2-Aminotetralins
Aminorexes
Tryptamines
α-Alkyltryptamines
Others
Benzofurans
Benzothiophenes
Indolizines
Isotryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Stimulants
Depressants
Hallucinogens
Entactogens
Psychiatric drugs
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=BK-NM-AMT&oldid=1323797786"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp